Loading...
XNAS
LMAT
Market cap1.92bUSD
Dec 05, Last price  
84.53USD
1D
-1.37%
1Q
-13.29%
Jan 2017
233.58%
IPO
1,210.54%
Name

LeMaitre Vascular Inc

Chart & Performance

D1W1MN
XNAS:LMAT chart
P/E
43.54
P/S
8.72
EPS
1.94
Div Yield, %
0.57%
Shrs. gr., 5y
2.30%
Rev. gr., 5y
13.40%
Revenues
220m
+13.63%
30,727,00034,628,00041,446,00048,720,00050,908,00056,060,00057,685,00056,735,00064,549,00071,097,00078,352,00089,151,000100,867,000105,568,000117,232,000129,366,000154,424,000161,651,000193,484,000219,863,000
Net income
44m
+46.28%
55,000-1,172,000-2,934,000-3,314,0001,598,0006,013,0002,143,0002,571,0003,202,0003,915,0007,758,00010,590,00017,177,00022,943,00017,934,00021,220,00026,907,00020,636,00030,105,00044,038,000
CFO
44m
+20.06%
-1,202,000-526,000-1,826,000581,0005,440,0007,052,0003,170,0004,722,0005,388,0005,512,00011,438,00016,896,00022,868,00019,506,00014,179,00034,800,00035,102,00025,378,00036,751,00044,124,000
Dividend
Aug 15, 20240.16 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
IPO date
Oct 19, 2006
Employees
591
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT